Stock-Based Compensation: The estimated market value of stock options, warrants and other stock-based compensation given to employees and/or vendors.
Seaport Therapeutics, Inc (SPTX) had Stock-Based Compensation of $39.43M for the most recently reported fiscal quarter, ending 2026-06-30.
| Income Statement Financials | |
-- |
|
$-62.60M |
|
-- |
|
-- |
|
$65.81M |
|
$-65.81M |
|
$3.46M |
|
$-62.35M |
|
$-62.35M |
|
$-62.60M |
|
$-62.60M |
|
$-62.60M |
|
$-62.60M |
|
$-65.81M |
|
$-65.82M |
|
35.24M |
|
35.24M |
|
$-1.78 |
|
$-1.78 |
|
| Balance Sheet Financials | |
$282.18M |
|
$0.36M |
|
$159.51M |
|
$441.68M |
|
$15.67M |
|
-- |
|
$3.40M |
|
$19.08M |
|
$422.60M |
|
$422.60M |
|
$422.60M |
|
53.53M |
|
| Cash Flow Statement Financials | |
$-46.31M |
|
$-175.65M |
|
$240.15M |
|
$46.50M |
|
$64.68M |
|
$18.18M |
|
|
Stock-Based Compensation |
$39.43M |
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
18.00 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-46.31M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-14.81% |
|
-14.81% |
|
-14.17% |
|
-14.81% |
|
$7.89 |
|
$-1.31 |
|
$-1.31 |
|